autologous natural killer cells Report issue

Cell therapy Experimental
AACT

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

Alternative names

autologous natural killer cells | expanded natural killer cells

Organizations (43)

Research & Development (43)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (44)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (44)


 

Antibody-Dependent Cell Cytotoxicity (Phase 1)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Colonic Neoplasms (Phase 1/Phase 2)

Drugs, Investigational (Phase 1)

Endometriosis (Phase 1)

Ependymoma (Phase 1)

Esophageal Neoplasms (Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Glioblastoma (Phase 1)

Glioma (Phase 1)

Hamartoma (Phase 2)

Hematologic Neoplasms (Phase 1)

HIV (Phase 2)

Immunotherapy (Phase 1)

Laryngeal Neoplasms (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia-Lymphoma, Adult T-Cell (Phase 1)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Liver Neoplasms (Phase 2)

Liver Transplantation (Phase 2)

Lung Neoplasms (Phase 1/Phase 2)

Lymphoma, Non-Hodgkin (Phase 1)

Medulloblastoma (Phase 1)

Melanoma (Phase 1)

Multiple Myeloma (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Natural Killer T-Cells (Phase 1)

Neoplasms (Phase 2)

Neuroblastoma (Phase 2)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 1/Phase 2)

Pneumonia (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Prostatic Neoplasms (Phase 1)

Sarcoma (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

T-Lymphocytes (Phase 2)

Tongue Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 43
  • # of Trial Organizations: 43

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue